Skip to content

Non-invasive screening of the breast with the DELSENI with the DMS method.

Non-invasive screening of the breast with the DELSENI with the DMS method. - DELSENI

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON46469
Enrollment
10
Registered
2018-02-22
Start date
2018-04-05
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer Mamma carcinoma

Interventions

None listed

Sponsors

Radboud Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - women 18 years and over; - signed informed consent; - planned ultrasound for clinical evaluation of palpable or mammographic abnormality in the breast; - physical and mental condition sufficient to undergo and complete examination.

Exclusion criteria

Exclusion criteria: - histologically confirmed malignant or pre-malignant abnormality in the breast before participation in this study; - status after major breast surgery; - breast biopsy in the last 6 weeks before scan with the DELSENI; - local inflammation of the breast (including ulcer, abces, etc); - chemotherapy in the last 5 years before participation; - no permission for reporting of incidental findings; - any mental state which prohibits giving informed consent; - any medical condition which prohibits safe or responsible participation of the subject or subject physically not able to undergo an extra scan

Design outcomes

Primary

MeasureTime frame
Improvement of the mathematical algorithm for image reconstruction of the DELSENI device.

Secondary

MeasureTime frame
Not applicable.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)